[Treatment of cannabis dependence].

Rev Prat

Département de psychiatrie et d'addictologie, hôpital universitaire Paul Brousse, 94804 Villejuif Cedex.

Published: January 2005

AI Article Synopsis

  • Cannabis is the most commonly used illegal drug globally, and historically, there have been no specific treatments for its users.
  • Until recently, cannabis was thought not to cause dependence, leading to a lack of management plans for those wanting to quit.
  • New studies indicate that cannabis dependence can be treated similarly to alcohol and tobacco dependence, suggesting a need for established treatment approaches.

Article Abstract

Cannabis is the most regularly used illicit drug in the world. Yet, until recently, there existed no therapeutic intervention for the users of this product. This was due to the fact that cannabis has always been considered a substance that doesn't lead to dependence and thus didn't necessitate a management plan for quitting. The results of the first studies in the domain of cannabis dependence suggest that this pathology responds to the same types of treatments for alcohol and tobacco dependence.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[treatment cannabis
4
cannabis dependence]
4
dependence] cannabis
4
cannabis regularly
4
regularly illicit
4
illicit drug
4
drug existed
4
existed therapeutic
4
therapeutic intervention
4
intervention users
4

Similar Publications

Background: Studies across multiple addictions have suggested that repetitive transcranial magnetic stimulation (rTMS) applied to the left dorsolateral prefrontal cortex (L-DLPFC) reduces cue-induced-craving (CIC), however there are no studies in treatment seeking participants with cannabis use disorder (CUD). In this secondary analysis of a previously completed trial, we explore whether a multi-session course of rTMS reduces CIC in CUD.

Methods: Seventy-one participants with ≥moderate CUD (age=30.

View Article and Find Full Text PDF

Cannabis sativa is recognized for its chemical diversity and therapeutic potential, particularly in addressing neurodegenerative diseases such as Alzheimer's disease (AD). Given the complexity of AD, where single-target therapies often prove inadequate, a multi-target approach utilizing cannabis-derived compounds may offer promising alternatives. This review first highlights the chemical diversity of cannabis by categorizing its compounds into cannabinoids and non-cannabinoids.

View Article and Find Full Text PDF

The most common and damaging plant parasitic nematodes are root-knot nematodes (RNK). Although hemp has been clearly infected by RNK, little information is available regarding the extent of the damage and losses caused. In addition, no information is available concerning hemp seed extracts' activity against RNK.

View Article and Find Full Text PDF

Introduction: The official implementation of pharmaceutical-grade cannabis raw materials for medicinal use has permitted doctors to prescribe and pharmacists to prepare cannabis-based formulations. The objective of the pharmaceutical development and manufacturing process optimization work was to propose a suppository formulation containing doses of 25 mg and 50 mg of tetra-hydrocannabinol (∆-9-THC) as an alternative to existing inhalable or orally administered formulations. The formulation could be used for rectal or vaginal administration, thereby providing dosage control in the treatment of endometriosis and other conditions involving pain.

View Article and Find Full Text PDF

Background: Intravenous nanoemulsions (NEs) are gaining attention as potential delivery systems for poorly water-soluble substances like cannabidiol (CBD). This study aimed to develop novel NEs based on CBD-enriched hemp oils and evaluate their physiochemical properties.

Methods: The stability of hemp oils enriched with various concentrations of CBD (0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!